Andersons pediatric cardiology 2370
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (77.06 KB, 3 trang )
Pediatricheartdisease,globalburdenof,1519–1533
congenital,1519–1520
rheumatic,1520
PediatricHeartNetwork,1516
Pediatricheartprograms,inlow-andmiddle-incomecountries
establishingandsustaining,1530–1531,1530f,1531t
qualityimprovementinitiativesfor,1532
trainingprogramsin,1531–1532
PediatricHeartTransplantStudy,1511t–1514t
Pediatricinfectiveendocarditis,incidenceof,1043
Pediatricpalliativecare,ethicalissuesand,1472
Pediatricpharmacotherapy,1430
PediMag(Thoratec)system,1187
inshort-termmechanicalcirculatorysupport,1207
PenicillinG,forinfectiveendocarditis,1053t
PentalogyofCantrell,914–915,914f
Percutaneouscentralvenouscatheters,useof,1550
Percutaneousmitralballoonvalvuloplasty
complicationsandoutcomesof,1035,1036t
contraindicationsto,1034–1035
indicationsfor,1034
mechanismof,1035,1035f
patientselectionin,1034,1034t
Perfusion,estimationof,100
Pericardialconstriction
cardiaccatheterizationin,1071,1072f
clinicalpresentationof,1070–1071
echocardiographyin,1071
investigationsfor,1071,1071f
managementof,1072–1073
pathophysiologyof,1070
restrictivecardiomyopathyand,1072,1073t
Pericardialcysts,1075
Pericardialdiseases,inchildren,1063–1075
Pericardialeffusion,1073–1074,1074f
incardiactumors,965,966f
clinicalpresentationof,1066
investigationsfor,1066–1067,1066f–1067f
managementof,1067–1068,1068f
pathophysiologyof,1065–1066
inprematurity,208
Pericarditis,1063–1065,1064t
acute,1063
bacterial,1068–1069
chylopericardium,1070
diagnosticevaluationof,1063–1064,1065f
HIV-related,1069
hypothyroidismand,1069
neoplasticdiseaseand,1069–1070
recurrent,1065
renalfailureand,1069
inrheumaticfever,1003–1004,1003f,1007–1008
treatmentof,1064–1065
tubercular,1069
viral,1068
Pericardium
absenceof,1074–1075,1075f
anatomyof,17
congenitalanomaliesof,1074–1075
congenitaldeficiencyof,915,915f–916f
pericardialcysts,1075
volumeloopof,1064f
Perinatalmortalityrate,definitionof,190b
Peripheralchemoreceptors,1359
Peripheralreceptors,1358–1359
Peripheralvasculardisease,inFontan-associatedliverdisease,1334
Peripheralvascularline,inFontanpathway,1275
Periventricularleukomalacia,incongenitalbraindisease,1396–1397
Permanentformofjunctionalreciprocatingtachycardia(PJRT),137,346–347,
347f
Permissibilityofwithdrawal,ethicalissuesand,1472–1474
Peronealmuscularatrophy,cardiacinvolvementin,1106
Persistentaneurysms,inKawasakidisease,984
Persistentlypatentarterialduct,756–757,760f–762f
angiographyin,763–764,764f
cardiaccatheterizationin,763–764
chestradiographyfor,762–763,763f
clinicalfeaturesof,762
closureincatheterizationlaboratoryin,768–769,768f–769f
complicationsof,765–770
aneurysmoftheductand,767,767f
congestiveheartfailurein,765
infectiveendarteritis,765–766
pulmonaryhypertensionand,766–767
diagnosticproblemswith,764–765
echocardiographyin,763,763f
effectonlifeexpectancyof,765
electrocardiogramfor,762
epidemiologyof,760
geneticfactorsof,760–761
infectionandenvironmentalfactorsof,761
investigationsfor,762–765
naturalhistoryin,765
pathophysiologyof,761
physicalexaminationfor,762
spontaneousclosureof,765
surgicalinterventionfor,767–768
